The National Task Force on COVID-19 recently decided against using which drug in clinical management protocols?

1. 

The National Task Force on COVID-19 recently decided against using which drug in clinical management protocols?
[A]. Itolizumab
[B]. Chloroquine
[C]. Favilavir
[D]. Fusogenix

Answer: Option A

Explanation:

The National Task Force on COVID-19 recently decided against using Itolizumab in clinical management protocols. The Drugs Controller General of India (DCGI) had earlier approved for "restricted emergency use" of the drug.

Workspace Report
Leave a Comment

Current Affairs :: Current Affairs 2020 : More Exercises

Questions & Answers

Aptitude Chemical Engineering Civil Engineering Computer Science & Engineering Current Affairs Data Interpretation Electrical & Electronics Engineering Electronics & Communication Engineering General Knowledge Logical Reasoning Mechanical Engineering Non Verbal Reasoning Verbal Ability Verbal Reasoning

Interviews

HR Interview

Jobs

Sarkari Jobs

Results

Rojgar ResultSarkari Result

Admission

Admission 2023

Admit Card

Admit Card 2023

Answer Key

Answer Key 2023